AxoGen Company Profile (NASDAQ:AXGN)

About AxoGen (NASDAQ:AXGN)

AxoGen logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AXGN
  • CUSIP: N/A
  • Web: www.axogeninc.com
Capitalization:
  • Market Cap: $541.11 million
  • Outstanding Shares: 33,095,000
Average Prices:
  • 50 Day Moving Avg: $15.83
  • 200 Day Moving Avg: $12.51
  • 52 Week Range: $6.45 - $17.25
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -232.14
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $45.24 million
  • Price / Sales: 11.89
  • Book Value: $0.37 per share
  • Price / Book: 43.92
Profitability:
  • EBIDTA: ($8,230,000.00)
  • Net Margins: -32.05%
  • Return on Equity: -155.78%
  • Return on Assets: -31.67%
Debt:
  • Debt-to-Equity Ratio: 1.67%
  • Current Ratio: 3.83%
  • Quick Ratio: 3.28%
Misc:
  • Average Volume: 209,933 shs.
  • Beta: 0.27
  • Short Ratio: 6.09
 
Frequently Asked Questions for AxoGen (NASDAQ:AXGN)

What is AxoGen's stock symbol?

AxoGen trades on the NASDAQ under the ticker symbol "AXGN."

How were AxoGen's earnings last quarter?

AxoGen, Inc. (NASDAQ:AXGN) announced its quarterly earnings data on Thursday, May, 4th. The company reported ($0.11) EPS for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.01. The firm earned $12.24 million during the quarter, compared to the consensus estimate of $11.83 million. AxoGen had a negative return on equity of 155.78% and a negative net margin of 32.05%. View AxoGen's Earnings History.

When will AxoGen make its next earnings announcement?

AxoGen is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for AxoGen.

Where is AxoGen's stock going? Where will AxoGen's stock price be in 2017?

5 equities research analysts have issued 12-month target prices for AxoGen's stock. Their predictions range from $11.00 to $18.00. On average, they expect AxoGen's share price to reach $14.38 in the next year. View Analyst Ratings for AxoGen.

Who are some of AxoGen's key competitors?

Who owns AxoGen stock?

AxoGen's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (1.85%), Perkins Capital Management Inc. (1.68%), Pennsylvania Trust Co (0.17%), Campbell & CO Investment Adviser LLC (0.06%) and Bank of Montreal Can (0.05%). Company insiders that own AxoGen stock include Amy Mcbride Wendell, James E Flynn, John P Engels, Joseph M Mandato, Karen L Zaderej and Peter J Mariani. View Institutional Ownership Trends for AxoGen.

Who sold AxoGen stock? Who is selling AxoGen stock?

AxoGen's stock was sold by a variety of institutional investors in the last quarter, including Pennsylvania Trust Co and Perkins Capital Management Inc.. View Insider Buying and Selling for AxoGen.

Who bought AxoGen stock? Who is buying AxoGen stock?

AxoGen's stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd. and Campbell & CO Investment Adviser LLC. Company insiders that have bought AxoGen stock in the last two years include Amy Mcbride Wendell, John P Engels, Karen L Zaderej and Peter J Mariani. View Insider Buying and Selling for AxoGen.

How do I buy AxoGen stock?

Shares of AxoGen can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AxoGen's stock price today?

One share of AxoGen stock can currently be purchased for approximately $16.25.


MarketBeat Community Rating for AxoGen (NASDAQ AXGN)
Community Ranking:  3.5 out of 5 (   )
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  98
MarketBeat's community ratings are surveys of what our community members think about AxoGen and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for AxoGen (NASDAQ:AXGN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.38 (11.54% downside)

Analysts' Ratings History for AxoGen (NASDAQ:AXGN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/29/2017Cantor FitzgeraldInitiated CoverageOverweight -> Overweight$18.00HighView Rating Details
5/19/2017WedbushReiterated RatingOutperform$17.00 -> $14.00HighView Rating Details
3/6/2017Roth CapitalInitiated CoverageBuy -> Buy$14.50N/AView Rating Details
11/22/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
11/22/2016Lake Street CapitalUpgradeHold -> Buy$9.00 -> $11.00N/AView Rating Details
(Data available from 7/27/2015 forward)

Earnings

Earnings History for AxoGen (NASDAQ:AXGN)
Earnings by Quarter for AxoGen (NASDAQ:AXGN)
Earnings History by Quarter for AxoGen (NASDAQ AXGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2017($0.08)N/AView Earnings Details
5/4/2017Q1 2017($0.10)($0.11)$11.83 million$12.24 millionViewListenView Earnings Details
2/22/2017Q4 2016($0.09)($0.10)$11.41 millionViewListenView Earnings Details
11/2/2016Q3 2016($0.08)($0.08)$11.21 million$11.21 millionViewN/AView Earnings Details
8/3/2016Q2($0.12)($0.09)$9.28 million$10.38 millionViewN/AView Earnings Details
11/5/2015Q3 2015($0.12)($0.11)$6.70 million$8.15 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.15)($0.13)$5.89 million$6.42 millionViewN/AView Earnings Details
5/5/2015Q1 2015($0.17)($0.16)$4.90 million$4.95 millionViewN/AView Earnings Details
11/13/2014Q3 2014($0.24)($0.19)$4.67 millionViewN/AView Earnings Details
8/4/2014Q2 2014($0.22)($0.21)$3.30 million$4.21 millionViewN/AView Earnings Details
4/30/2014Q1 2014($0.26)($0.24)$2.75 million$3.14 millionViewN/AView Earnings Details
3/6/2014($0.22)($0.24)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AxoGen (NASDAQ:AXGN)
2017 EPS Consensus Estimate: ($0.25)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173($0.12)($0.07)($0.10)
Q2 20173($0.06)($0.04)($0.05)
Q3 20173($0.05)($0.03)($0.04)
Q4 20173($0.09)($0.04)($0.06)
Q1 20181$0.01$0.01$0.01
Q2 20181$0.03$0.03$0.03
Q3 20181$0.04$0.04$0.04
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AxoGen (NASDAQ:AXGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for AxoGen (NASDAQ:AXGN)
Insider Ownership Percentage: 9.33%
Institutional Ownership Percentage: 63.49%
Insider Trades by Quarter for AxoGen (NASDAQ:AXGN)
Institutional Ownership by Quarter for AxoGen (NASDAQ:AXGN)
Insider Trades by Quarter for AxoGen (NASDAQ:AXGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/7/2016Amy Mcbride WendellDirectorBuy13,333$7.50$99,997.50View SEC Filing  
10/7/2016John P EngelsVPBuy4,000$7.50$30,000.00View SEC Filing  
10/7/2016Karen L ZaderejCEOBuy10,000$7.50$75,000.00View SEC Filing  
10/7/2016Peter J MarianiCFOBuy3,333$7.50$24,997.50View SEC Filing  
8/9/2016Joseph M MandatoDirectorSell149,618$8.54$1,277,737.72View SEC Filing  
8/8/2016Joseph M MandatoDirectorSell107,450$8.63$927,293.50View SEC Filing  
7/21/2016James E FlynnInsiderSell102,136$6.70$684,311.20View SEC Filing  
7/18/2016James E FlynnInsiderSell279,303$7.53$2,103,151.59View SEC Filing  
9/18/2015James E FlynnInsiderSell345,000$5.50$1,897,500.00View SEC Filing  
6/3/2015Joseph M MandatoDirectorBuy6,500$3.10$20,150.00View SEC Filing  
6/2/2015Lee Robert Johnston JrInsiderBuy5,000$3.06$15,300.00View SEC Filing  
4/8/2015James E FlynnInsiderSell144,385$3.25$469,251.25View SEC Filing  
12/10/2014Lee Robert Johnston JrCFOBuy10,000$3.06$30,600.00View SEC Filing  
8/12/2014Mark Stephen GoldDirectorBuy20,000$2.29$45,800.00View SEC Filing  
8/8/2014Mark Stephen GoldDirectorBuy11,000$2.31$25,410.00View SEC Filing  
6/6/2014Lee Robert Johnston JrCFOBuy10,000$2.58$25,800.00View SEC Filing  
6/3/2014Gregory Gene FreitagCFOBuy5,200$2.45$12,740.00View SEC Filing  
6/3/2014Karen L ZaderejCEOBuy5,000$2.43$12,150.00View SEC Filing  
5/20/2014Jill F SchiaparelliSVPBuy2,000$2.63$5,260.00View SEC Filing  
5/12/2014Karen L ZaderejCEOBuy5,000$2.70$13,500.00View SEC Filing  
5/7/2014Mark Stephen GoldDirectorBuy1,977$2.60$5,140.20View SEC Filing  
3/13/2014Karen L ZaderejCEOBuy1,500$3.49$5,235.00View SEC Filing  
8/29/2013Shawn F MccarreySVPBuy25,000$3.21$80,250.00View SEC Filing  
8/24/2013Shawn F MccarreySVPBuy5,000$3.00$15,000.00View SEC Filing  
8/14/2013Jill F SchiaparelliSVPBuy5,000$3.00$15,000.00View SEC Filing  
8/14/2013John Frederick HarperDirectorBuy66,666$3.00$199,998.00View SEC Filing  
8/14/2013Karen L ZaderejCEOBuy8,334$3.00$25,002.00View SEC Filing  
12/4/2012Jill F SchiaparelliSVPBuy2,000$2.55$5,100.00View SEC Filing  
11/29/2012Jill F SchiaparelliSVPBuy1,000$2.70$2,700.00View SEC Filing  
11/15/2012Jill F SchiaparelliSVPBuy2,750$2.56$7,040.00View SEC Filing  
10/1/2012John Frederick HarperDirectorBuy86,557$3.61$312,470.77View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for AxoGen (NASDAQ:AXGN)
Latest Headlines for AxoGen (NASDAQ:AXGN)
Source:
DateHeadline
americanbankingnews.com logoAxoGen, Inc. (AXGN) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 26 at 7:56 AM
americanbankingnews.com logoAxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - July 25 at 8:24 AM
americanbankingnews.com logoZacks: Brokerages Anticipate AxoGen, Inc. (NASDAQ:AXGN) Will Post Quarterly Sales of $14.40 Million
www.americanbankingnews.com - July 22 at 8:00 AM
americanbankingnews.com logo Analysts Anticipate AxoGen, Inc. (NASDAQ:AXGN) to Post -$0.08 EPS
www.americanbankingnews.com - July 20 at 10:18 PM
finance.yahoo.com logoAxoGen, Inc. Discloses Terms of Recent Equity Award
finance.yahoo.com - July 20 at 5:44 PM
americanbankingnews.com logoGlobus Medical (GMED) & AxoGen (NASDAQ:AXGN) Critical Review
www.americanbankingnews.com - July 20 at 5:21 PM
nasdaq.com logoAxoGen, Inc. to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday,
www.nasdaq.com - July 19 at 5:29 PM
finance.yahoo.com logoAxoGen, Inc. to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 2, 2017
finance.yahoo.com - July 19 at 5:29 PM
americanbankingnews.com logoInteger Holdings (ITGR) & AxoGen (NASDAQ:AXGN) Head to Head Analysis
www.americanbankingnews.com - July 16 at 12:26 PM
americanbankingnews.com logoComparing Sunshine Heart (SSH) & AxoGen (NASDAQ:AXGN)
www.americanbankingnews.com - July 16 at 12:28 AM
americanbankingnews.com logoReviewing Sunshine Heart (SSH) and AxoGen (NASDAQ:AXGN)
www.americanbankingnews.com - July 15 at 10:04 PM
americanbankingnews.com logoReviewing Globus Medical (GMED) and AxoGen (NASDAQ:AXGN)
www.americanbankingnews.com - July 15 at 8:07 AM
americanbankingnews.com logoAxoGen, Inc. (NASDAQ:AXGN) Forecasted to Earn FY2017 Earnings of ($0.30) Per Share
www.americanbankingnews.com - July 6 at 9:38 AM
americanbankingnews.com logoAxoGen, Inc. (AXGN) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - June 29 at 6:40 PM
americanbankingnews.com logoAxoGen, Inc. (AXGN) Receives New Coverage from Analysts at Cantor Fitzgerald
www.americanbankingnews.com - June 29 at 6:02 PM
americanbankingnews.com logoAxoGen (AXGN) & Integer Holdings (ITGR) Head to Head Review
www.americanbankingnews.com - June 29 at 8:05 AM
americanbankingnews.com logo$14.40 Million in Sales Expected for AxoGen, Inc. (AXGN) This Quarter
www.americanbankingnews.com - June 28 at 10:34 AM
americanbankingnews.com logoAxoGen, Inc. (AXGN) Expected to Announce Earnings of -$0.08 Per Share
www.americanbankingnews.com - June 26 at 6:38 PM
seekingalpha.com logoAxoGen (AXGN) Presents at JMP Securities Life Sciences Conference 2017 - Slideshow
seekingalpha.com - June 22 at 3:52 PM
americanbankingnews.com logoAxoGen, Inc. (AXGN) Rating Increased to Hold at ValuEngine
www.americanbankingnews.com - June 12 at 10:58 PM
finance.yahoo.com logoETFs with exposure to AxoGen, Inc. : June 8, 2017
finance.yahoo.com - June 8 at 4:29 PM
finance.yahoo.com logoAxoGen, Inc. to Present at the JMP Securities Life Sciences Conference
finance.yahoo.com - June 7 at 7:41 AM
finance.yahoo.com logoAxoGen, Inc. (AXGN)
finance.yahoo.com - June 5 at 12:59 PM
americanbankingnews.com logoZacks: Brokerages Expect AxoGen, Inc. (AXGN) Will Announce Quarterly Sales of $14.40 Million
www.americanbankingnews.com - June 2 at 1:16 PM
americanbankingnews.com logo-$0.07 EPS Expected for AxoGen, Inc. (AXGN) This Quarter
www.americanbankingnews.com - May 31 at 2:26 PM
seekingalpha.com logoAxoGen's (AXGN) CEO Karen Zaderej Hosts 2017 Annual Shareholders' Meeting (Transcript)
seekingalpha.com - May 25 at 2:08 AM
finance.yahoo.com logoAxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session
finance.yahoo.com - May 22 at 10:08 AM
streetinsider.com logoAxoGen (AXGN): Management Meeting Highlights New Opportunity - Wedbush
www.streetinsider.com - May 19 at 9:21 AM
americanbankingnews.com logoWedbush Reaffirms Outperform Rating for AxoGen, Inc. (AXGN)
www.americanbankingnews.com - May 19 at 7:42 AM
finance.yahoo.com logoETFs with exposure to AxoGen, Inc. : May 15, 2017
finance.yahoo.com - May 15 at 4:16 PM
finance.yahoo.com logoAxoGen, Inc. :AXGN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
finance.yahoo.com - May 10 at 3:58 PM
americanbankingnews.com logoFY2019 EPS Estimates for AxoGen, Inc. Raised by Wedbush (AXGN)
www.americanbankingnews.com - May 8 at 12:12 PM
americanbankingnews.com logoAxoGen, Inc. (AXGN) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS
www.americanbankingnews.com - May 5 at 3:58 PM
americanbankingnews.com logoZacks: Brokerages Anticipate AxoGen, Inc. (AXGN) to Announce -$0.05 EPS
www.americanbankingnews.com - May 5 at 2:25 PM
finance.yahoo.com logoAxoGen, Inc. Reports 2017 First Quarter Financial Results
finance.yahoo.com - May 4 at 8:55 PM
finance.yahoo.com logoAxoGen reports 1Q loss
finance.yahoo.com - May 4 at 8:55 PM
finance.yahoo.com logoInvestor Network: AxoGen, Inc. to Host Earnings Call
finance.yahoo.com - May 4 at 3:53 PM
finance.yahoo.com logoETFs with exposure to AxoGen, Inc. : May 2, 2017
finance.yahoo.com - May 3 at 11:52 AM
americanbankingnews.com logoSomewhat Negative News Coverage Very Likely to Affect AxoGen (AXGN) Stock Price
www.americanbankingnews.com - May 2 at 6:10 PM
americanbankingnews.com logoAxoGen, Inc. (AXGN) Set to Announce Earnings on Thursday
www.americanbankingnews.com - May 2 at 10:24 AM
americanbankingnews.com logoSomewhat Negative News Coverage Extremely Likely to Affect AxoGen (AXGN) Stock Price
www.americanbankingnews.com - April 29 at 11:14 AM
americanbankingnews.com logoAxoGen (AXGN) Given News Sentiment Rating of 0.56
www.americanbankingnews.com - April 24 at 1:00 PM
americanbankingnews.com logoSomewhat Positive Press Coverage Very Likely to Affect AxoGen (AXGN) Stock Price
www.americanbankingnews.com - April 21 at 11:39 AM
americanbankingnews.com logoAxoGen (AXGN) Earning Somewhat Positive Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 18 at 12:20 PM
finance.yahoo.com logoETFs with exposure to AxoGen, Inc. : April 17, 2017
finance.yahoo.com - April 17 at 3:42 PM
americanbankingnews.com logoAxoGen, Inc. (AXGN) Short Interest Up 2.0% in March
www.americanbankingnews.com - April 17 at 10:48 AM
americanbankingnews.com logoAxoGen, Inc. (AXGN) Expected to Post Quarterly Sales of $11.83 Million
www.americanbankingnews.com - April 16 at 8:38 AM
americanbankingnews.com logoAxoGen (AXGN) Receiving Favorable Media Coverage, Report Shows
www.americanbankingnews.com - April 15 at 10:55 AM
americanbankingnews.com logoAxoGen, Inc. (AXGN) Expected to Announce Earnings of -$0.10 Per Share
www.americanbankingnews.com - April 14 at 4:32 PM
finance.yahoo.com logoAxoGen, Inc. to Report First Quarter 2017 Financial Results and Host Conference Call on Thursday, May 4, 2017
finance.yahoo.com - April 14 at 11:19 AM

Social

Chart

AxoGen (AXGN) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff